Rapid Rx Quiz: Diabetes Drugs

Mary L. Windle, PharmD


May 13, 2022

Because ketoacidosis, including fatal cases, has been reported in patients treated with SGLT2 inhibitors, including empagliflozin, consider factors that may predispose a patient to ketoacidosis before initiating therapy. These include any cause of pancreatic insulin deficiency, such as alcohol abuse or extreme caloric restriction.

Learn more about empagliflozin.

.This Rapid Rx Study Quiz was excerpted and adapted from the Medscape articles Metformin, Which Patients With Type 2 Diabetes Need SGLT2 Inhibitors?, Sitagliptin, Type 2 Diabetes Podcast, Semaglutide, FDA Okays Semaglutide Higher Dose, 2 mg/Week, for Type 2 Diabetes, and Empagliflozin.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.